Massimo Federici is currently Professor of Medicine and Nutrition at the University of Rome "Tor Vergata" Medical School and Director of the Center for Atherosclerosis at the Tor Vergata Medical School hospital. After a Medical Doctor degree (1994) he trained in Endocrinology and Metabolism at the University of Rome actively working in both clinical and molecular research. After a post-doc at the Joslin Diabetes Research Laboratory at Harvard Medical School in Boston, USA, he returned to Rome to start a new laboratory dedicated to the vascular complications of metabolic diseases. Among the major interests the role of TIMP3 and ADAM17 activation as a mechanism linking insulin resistance, diabetic complications and atherosclerosis. In 2006 he was awarded the Morgagni Prize Silver Award and with the European Association for the Study of Diabetes Rising Star Lecture.
Back to all editors